SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-20-049253
Filing Date
2020-02-26
Accepted
2020-02-26 08:35:22
Documents
10
Effectiveness Date
2020-02-26

Document Format Files

Seq Description Document Type Size
1 S-3ASR d879189ds3asr.htm S-3ASR 302380
2 EX-4.1 d879189dex41.htm EX-4.1 336717
3 EX-4.2 d879189dex42.htm EX-4.2 327148
4 EX-4.3 d879189dex43.htm EX-4.3 40657
5 EX-4.4 d879189dex44.htm EX-4.4 40435
6 EX-5.1 d879189dex51.htm EX-5.1 31262
7 EX-23.1 d879189dex231.htm EX-23.1 2071
8 GRAPHIC g879189dsp174.jpg GRAPHIC 2231
9 GRAPHIC g879189g99d28.jpg GRAPHIC 62588
10 GRAPHIC g879189page174.jpg GRAPHIC 6716
  Complete submission text file 0001193125-20-049253.txt   1180669
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-236639 | Film No.: 20653386
SIC: 2834 Pharmaceutical Preparations